Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Chemotherapy-Induced Thrombocytopenia”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT05944211
What this trial is testing

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia(CIT) in Patients With Acute Myeloid Leukemia

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
RenJi Hospital 72
Testing effectiveness (Phase 2)Ended earlyNCT03622931
What this trial is testing

Patients With Relapsed Ovarian Cancer (2nd and 3rd Line) Treated With Chemotherapy According to AGO Guidelines

Who this might be right for
Ovarian Cancer
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 21
Large-scale testing (Phase 3)WithdrawnNCT03343847
What this trial is testing

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma.

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Amgen
Testing effectiveness (Phase 2)Looking for participantsNCT07492693
What this trial is testing

Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors

Who this might be right for
Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors
Changhai Hospital 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07286032
What this trial is testing

Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia

Who this might be right for
Patients With Chemotherapy-Induced Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 150
Testing effectiveness (Phase 2)Ended earlyNCT01676961
What this trial is testing

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+2 more
NYU Langone Health 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07043894
What this trial is testing

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients

Who this might be right for
Solid TumorsHematological TumorChildren+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05772546
What this trial is testing

Avatrombopag vs. Placebo for CIT in GI Malignancies

Who this might be right for
Gastrointestinal CancerGastrointestinal NeoplasmsChemotherapy-Induced Thrombocytopenia
Hanny Al-Samkari, MD 60
Testing effectiveness (Phase 2)Study completedNCT00003619
What this trial is testing

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
Drexel University College of Medicine
Testing effectiveness (Phase 2)UnknownNCT05672420
What this trial is testing

Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies

Who this might be right for
Hematologic NeoplasmsNeutropeniaAnemia+3 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 181
Not applicableUnknownNCT03049774
What this trial is testing

The Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Angde Biotech Pharmaceutical Co., Ltd. 2,000
Testing effectiveness (Phase 2)Study completedNCT01147809
What this trial is testing

Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag

Who this might be right for
Thrombocytopaenia
GlaxoSmithKline 130
Testing effectiveness (Phase 2)Study completedNCT05963334
What this trial is testing

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Advanced Epithelial Ovarian Cancer
Cairo University 49
Very early researchLooking for participantsNCT07048249
What this trial is testing

Single Arm Romiplostim to Prevent CIT

Who this might be right for
Ewings SarcomaChemotherapy Induced Thrombocytopenia
Children's Hospital Medical Center, Cincinnati 26
Not applicableUnknownNCT02344979
What this trial is testing

The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC

Who this might be right for
Thrombocytopenia
Shenyang Sunshine Pharmaceutical Co., LTD. 120
Not applicableStudy completedNCT05688306
What this trial is testing

To Evaluate Thrombosis Risk in Chemotherapy Patients With Solid Tumors Who Receiving Thrombocytopenia Treatment

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Liaoning Cancer Hospital & Institute 3,494
Large-scale testing (Phase 3)Active Not RecruitingNCT03937154
What this trial is testing

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Amgen 145
Testing effectiveness (Phase 2)UnknownNCT06099925
What this trial is testing

The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Malignancies

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 48
Early research (Phase 1)Ended earlyNCT01345214
What this trial is testing

The Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
Ono Pharma USA Inc 17
Testing effectiveness (Phase 2)Study completedNCT01516619
What this trial is testing

Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia

Who this might be right for
Non-Hodgkin Lymphoma
Andres J. M. Ferreri 3
Load More Results